TABLE 1.
Complete case enrollment and analyze the data set of 44 COVID‐19 patients in experimental group and control group
| Subject distribution | Experimental group (N = 26) | Control group (N = 18) | Total |
|---|---|---|---|
| Participants, n (%) | 26 (59.09) | 18 (40.91) | 44 (100.00) |
| Severe, n (%) | 16 (61.54) | 10 (38.46) | 26 (100.00) |
| Critical, n (%) | 10 (55.56) | 8 (44.44) | 18 (100.00) |
| Number of treatment, n (%) | 26 (59.09) | 18 (40.91) | 44 (100.00) |
| Severe, n (%) | 16 (61.54) | 10 (38.46) | 26(100.00) |
| Critical, n (%) | 10 (55.56) | 8 (44.44) | 18 (100.00) |
| Number of people who completed the test, n (%) | 25 (58.14) | 18 (41.86) | 43 (100.00) |
| Number of people who withdrew from the trial, n (%) | 1 (100.00) | 0 (0.00) | 1 (100.00) |
| Severe, n (%) | 0 (000.00) | 0 (0.00) | 0 (000.00) |
| Critical, n (%) | 1 (100.00) | 0 (0.00) | 1 (100.00) |
| Full analysis set, n (%) | 26 (59.09) | 18 (40.91) | 44 (100.00) |
| In line with the program set, n (%) | 24 (57.14) | 18 (42.86) | 42 (100.00) |
| Eliminate the number of trials, n (%) | 2 (100.00) | 0 (0.00) | 2 (100.00) |
| Severe, n (%) | 0 (000.00) | 0 (0.00) | 0 (000.00) |
| Critically ill, n (%) | 2 (100.00) | 0 (0.00) | 2 (100.00) |
| Security Analysis Set, n (%) | 26 (59.09) | 18 (40.91) | 44 (100.00) |
Note. “n” represents number.